LiverSource »  Faculty »  Medical Oncology »  Alan P. Venook, M.D.
 
Related Programs
Department of Surgery Websites

Make a Gift

A gift to the UCSF Department of Surgery can help physicians and scientist find treatments and cures for serious liver diseases such as hepatitis B & C, and liver cancer.

LiverSource »  Faculty »  Medical Oncology »  Alan P. Venook, M.D.

Alan P. Venook, M.D.

Professor of Clinical Medicine,
Division of Hematology Oncology
Department of Medicine
Chairman, UCSF Committee on Human Research

Contact Information

Box 1705, UCSF; San Francisco, CA 94143-1705
(415) 353-9888 (appts)
(415) 353-9959 (fax)
venook@cc.ucsf.edu

All Clinic Information

Education

  • Rutgers College, New Brunswick, New Jersey, BA, 1976, Biological Sciences
  • University of California San Francisco, MD, 1980, Medicine

Residencies

  • University of California San Francisco, Internship, 1981, Internal Medicine
  • University of California, Davis, Residency, 1985, Internal Medicine

Fellowships

  • University of California San Francisco, Fellowship, 1987, Hematology/Oncology

Postdoctoral Training

Board Certification

  • American Board of Internal Medicine
  • American Board of Internal Medicine: Medical Oncology - Subspecialty
  • American Board of Internal Medicine: Hematology - Subspecialty

Program Affiliations

  • GI Oncology Program
  • The Liver Center at UCSF
  • UCSF Helen Diller Family Comprehensive Cancer Center

Clinical Expertise

  • Anal Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Hepatocellular Carcinoma (Liver Cancer)
  • Liver Metastases
  • Lynch Syndrome
  • Pancreatic Cancer
  • Rectal Cancer
  • Stomach Cancer

Research Interests

  • Anal Cancer
  • Colon Cancer
  • Hepatocellular Carcinoma (Liver Cancer)
  • Liver Metastases
  • Rectal Cancer

Selected Publications

  1. Kelley RK, Venook AP. Nonadherence to Imatinib during an Economic Downturn. N Engl J Med. 2010 Aug 5; 363(6):596-8.
  2. Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, Gores G, Kerlan R, Merle P, O'Neil B, Poon R, Schwartz L, Tepper J, Yao F, Haller D, Mooney M, Venook A. Hepatocellular carcinoma: consensus recommendations of the national cancer institute clinical trials planning meeting. J Clin Oncol. 2010 Sep 1; 28(25):3994-4005.
  3. Roberts JP, Venook A, Kerlan R, Yao F. Hepatocellular carcinoma: Ablate and wait versus rapid transplantation. Liver Transpl. 2010 Aug; 16(8):925-9.
  4. Lencioni R, Marrero J, Venook A, Ye SL, Kudo M. Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study. Int J Clin Pract. 2010 Jul; 64(8):1034-41.
  5. Schwarz RE, Abou-Alfa GK, Geschwind JF, Krishnan S, Salem R, Venook AP. Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement. HPB (Oxford). 2010 Jun; 12(5):313-20.

X